Notably, the downregulation of ALDOA in tumor tissues highlights the metabolic reprogramming that occurs in cancer stem cells, potentially reflecting their unique metabolic dependencies compared to bulk tumor cells. This evidence concerns the gene ALDOA and neoplasm.